STAAR Surgical Company
STAA
$29.29
-$1.92-6.15%
NASDAQ
| 04/03/2026 | 01/02/2026 | 09/26/2025 | 06/27/2025 | 03/28/2025 | |
|---|---|---|---|---|---|
| Net Income | 5.21M | -18.31M | 8.88M | -16.81M | -54.21M |
| Total Depreciation and Amortization | 2.11M | 2.01M | 2.00M | 1.98M | 2.34M |
| Total Amortization of Deferred Charges | 104.00K | 409.00K | -- | -- | 53.00K |
| Total Other Non-Cash Items | 13.58M | 11.06M | 22.57M | 3.46M | 17.77M |
| Change in Net Operating Assets | -42.69M | 924.00K | -30.79M | -15.87M | 28.32M |
| Cash from Operations | -21.70M | -3.91M | 2.67M | -27.25M | -5.73M |
| Capital Expenditure | -443.00K | -1.68M | -883.00K | -1.79M | -1.47M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 2.59M | -17.74M | 6.17M | 26.91M | 36.82M |
| Cash from Investing | 2.15M | -19.42M | 5.28M | 25.12M | 35.35M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | 0.00 | 0.00 | 0.00 | -42.00K |
| Issuance of Common Stock | 174.00K | 114.00K | 2.97M | 12.00K | 377.00K |
| Repurchase of Common Stock | -1.87M | -164.00K | -1.98M | -4.55M | -1.28M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -1.69M | -50.00K | 983.00K | -4.54M | -948.00K |
| Foreign Exchange rate Adjustments | -45.00K | 374.00K | 91.00K | 686.00K | 286.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -21.29M | -23.01M | 9.02M | -5.98M | 28.96M |